Context Therapeutics Inc. (CNTX)
(Delayed Data from NSDQ)
$1.86 USD
-0.10 (-5.10%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.11 | -52.38% |
Earnings Summary
For their last quarter, Context Therapeutics Inc. (CNTX) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 50.00%. Look out for CNTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 70.27%.
Earnings History
Price & Consensus
Zacks News for CNTX
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
CNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services